cbdMD (YCBD) Risk Assessment

View and export this data going back to 2017. Start your Free Trial

What is cbdMD Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of cbdMD is: High Risk: High uncertainty.

Competitive Comparison of cbdMD's Risk Assessment

For the Drug Manufacturers - Specialty & Generic subindustry, cbdMD's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

cbdMD's Risk Assessment Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, cbdMD's Risk Assessment distribution charts can be found below:

* The bar in red indicates where cbdMD's Risk Assessment falls into.

cbdMD (AMEX:YCBD) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

cbdMD Risk Assessment Related Terms

Thank you for viewing the detailed overview of cbdMD's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

cbdMD (YCBD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » cbdMD Inc (AMEX:YCBD) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

YCBDPA.PFD:USA

Address

8845 Red Oak Boulevard, Charlotte, NC, USA, 28217

Website

https://www.cbdmd.com

cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD and hempMD. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD bath bombs, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.

Executives

Thomas Ronan Kennedy	officer: Interim CEO and CFO	8845 RED OAK BLVD, CHARLOTTE NC 28217
Bakari T. Sellers	director	4231 VOORHEES ROAD, DENMARK SC 29042
Raines William F Iii	director	8314 TOSOMOCK LANE, HUNTERSVILLE NC 28078
Scott G. Stephen	director	4249 NORTH WINCHESTER AVE., CHICAGO IL 60613
Sibyl Nichole Swift	director	730 HAWTHORNE LANE, APT 441, CHARLOTTE NC 28204
Kevin Macdermott	officer: President	9580 CALDWELL RD, MOUNT ULLA NC 28125
Wiesehan John J Iii	officer: Chief Revenue Officer	8845 RED OAK BOULEVARD, CHARLOTTE NC 28217
Sim Farar	director	8845 RED OAK BOULEVARD, CHARLOTTE NC 28217
Martin A. Sumichrast	director, officer: Chairman of the Board and CEO	11125 COLONIAL COUNTRY LANE, CHARLOTTE NC 28277
Raymond Scott Coffman	director	230 S. TRYON ST., #1302, CHARLOTTE NC 28202
Peter J. Ghiloni	director	115 DEER ESTATES LANE, PONTE VEDRA BEACH FL 32082
Mark S Elliott	officer: CFO & COO	C/O LEVEL BRANDS, INC., 4521 SHARON ROAD, SUITE 450, CHARLOTTE NC 28211
Gregory C Morris	director	421 CRANBORNE CHASE, FORT MILL SC 29708
Caryn Nicole Dunayer	officer: President	8476 CATAWBA DOVE DR., BELMONT NC 28012
Erik Sterling	10 percent owner	5505 KALANIANAOLE HWY, HONOLULU HI 96821